您的位置: 首页 > 农业专利 > 详情页

SYNTHETIC HERPES SIMPLEX VIRUSES TYPE-1 FOR TREATMENT OF CANCERS
专利权人:
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
发明人:
KOUSOULAS, KONSTANTIN G.
申请号:
CA2687301
公开号:
CA2687301C
申请日:
2008.05.09
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
A recombinant herpes simplex virus type-1 (HSV-1) has been constructed thatcarries a deletion of one of the twoviral .gamma.1 34.5 genes and other immediate early genes, which render thevirus able to selectively replicate in cancer cells but not efficientlyreplicate in normal cells, and in which specific mutations have beenintroduced to enable the virus to spread among cancercells by virus-induced fusion. Specifically, syncytial mutations have beenintroduced in the genes coding for glycoprotein B andglycoprotein K of the virus, enabling high replication and spread of the virusin cancer cells in the presence of substantially loweramounts of .gamma.1 34.5 protein, which is required for optimum infectiousvirus produced and virus-induced cell fusion. Other knownsyncytial mutations could also be introduced that would render the virus ableto cause extensive virus-induced cell fusion. In addition,other known mutations can be introduced to limit the spread of the virus tothe nervous system. These altered viruses or theisolated bacterial chromosomes could be used to treat various cancersincluding breast, liver, colon, and other tissues.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充